EARLY DISEASE PROGRESSION IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: CLINICAL AND CYTOGENETIC PREDICTORS IN A REAL-WORLD COHORT

EHA Library, Hakan Goker, 4209644

EXTENDED FOLLOW-UP OF LUSPATERCEPT TREATMENT IN LOWER-RISK, TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS: HEMATOLOGIC RESPONSE AND MULTILINEAGE EFFECTS

EHA Library, Mara Memoli, 4209646

IMMUNOPHENOTYPIC AND MOLECULAR GENETIC MARKERS IN MDS AS PREDICTORS OF DISEASE OUTCOME.

EHA Library, Anna Shevchenko, 4209647

THREE VENETOCLAX SCHEDULES AND CORRELATION WITH OVERALL SURVIVAL IN HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Maher Salamoon, 4209649

ANALYSIS OF THE DISTRIBUTION CHARACTERISTICS AND PROGNOSTIC IMPACT OF GENE MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES BASED ON NEXT-GENERATION SEQUENCING

EHA Library, Rui Zhang, 4209650

REAL-WORLD OUTCOMES OF THYMOGLOBULIN-BASED IMMUNOSUPPRESSION FOR ADULT APLASTIC ANEMIA IN COLOMBIA: A 12-YEAR SINGLE-CENTER COHORT

EHA Library, Fabian Ahumada, 4209654

CSNK1A1 AND DDX41 MUTATIONS IN MYELODYSPLASTIC NEOPLASMS WITH DELETION OF LONG ARM OF CHROMOSOME 5

EHA Library, Valeriya Okhota, 4209655

OBSERVATIONAL AND GENETIC ASSOCIATION OF MYELODYSPLASTIC SYNDROMES (MDS) AND AUTOIMMUNE DISEASES IN ADULTS

EHA Library, Shuqian Xu, 4209656

FROM MYELODYSPLASTIC SYNDROME TO ACUTE MYELOID LEUKEMIA: DIAGNOSTIC PATHWAYS AND REAL-WORLD DISEASE EVOLUTION

EHA Library, Bianca-Andreea Cristian, 4209657

CLINICAL OUTCOMES OF HYPOMETHYLATING AGENTS IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME: A SYSTEMATIC REVIEW OF PUBLISHED CASE SERIES AND REPORTS

EHA Library, Joed Ivan Mata, 4209658

A SCOPING ANALYSIS OF MATERNAL, OBSTETRIC, AND NEONATAL RESULTS IN PREGNANT WOMEN WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Shehab Fareed, 4209662

THE INFLUENCE OF INTESTINAL FLORA AND ITS METABOLITE BUTYRIC ACID ON SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 4209663

BONE MARROW FAILURE IS ASSOCIATED WITH CHANGES IN GENE EXPRESSION IN BOTH TYPES OF STROMAL PRECURSORS FROM THE BONE MARROW OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Irina Shipounova, 4209666

DEVELOPING MRNA-BASED THERAPEUTICS FOR THE TREATMENT OF DIAMOND BLACKFAN ANEMIA SYNDROME

EHA Library, Olivia Delfino, 4209670

SHARED T-CELL RECEPTOR CLONOTYPES IN FAMILIAL APLASTIC ANEMIA ASSOCIATED WITH HLA-A*02:06 LOSS DUE TO 6P LOSS OF HETEROZYGOSITY

EHA Library, Tatsuya Imi, 4209671

GPI ANCHOR EXPRESSION AT EARLY STAGES OF MYELOID MATURATION IN NON-NEOPLASTIC PAEDIATRIC BONE MARROW.

EHA Library, Anna Stelmaszczyk-Emmel, 4209677

CLINICAL BURDEN OF PNH PATIENTS WITH HEMOGLOBIN BETWEEN ≥10 AND <12 G/DL: RESULTS FROM A MULTINATIONAL REAL-WORLD STUDY

EHA Library, Jörg Schubert, 4209678

EFFICACY AND SAFETY OF RAVULIZUMAB VERSUS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Mehak Dang, 4209679

COMPARATIONS OF EFFICACY OF IMMUNOSUPPRESSIVE THERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE APLASTIC ANEMIA : A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Yatong Lv, 4209680

OPTIMIZING ORAL FRONT-LINE THERAPY IN APLASTIC ANEMIA: REAL-WORLD EFFICACY OF ELTROMBOPAG AND CYCLOSPORINE IN AN OUTPATIENT SETTING FROM LOW AND MIDDLE-INCOME COUNTRY

EHA Library, Gaurav Ojha, 4209685

COMPARATIVE EFFICACY OF NOVEL COMPLEMENT INHIBITORS VERSUS ECULIZUMAB IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A META-ANALYSIS OF RANDOMIZED TRIALS

EHA Library, Luiza Veloso, 4209686

EARLY ACCESS PROGRAM FOR DANICOPAN (ALXN2040) AS ADD-ON TREATMENT TO ECULIZUMAB OR RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): THE ITALIAN REAL-WORLD.

EHA Library, Bruno Fattizzo, 4209690

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), AN OVERVIEW IN BRAZIL

EHA Library, Catherine Moura, 4209691

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA: A 20-YEAR SINGLE-CENTER EXPERIENCE

EHA Library, Malek Benakli, 4209692

SUPERIOR EFFICACY OF CSA PLUS ATG OVER CSA MONOTHERAPY IN PEDIATRIC TRANSFUSION-INDEPENDENT MODERATE APLASTIC ANEMIA

EHA Library, hongmin li, 4209693

OUTCOMES OF DIRECT ORAL ANTICOAGULANT USE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: A SYSTEMATIC REVIEW

EHA Library, Stephanie Quon, 4209695

SEVERE IDIOPATHIC NEUTROPENIA: IMMUNOSUPPRESSIVE THERAPY IN CHILDREN REFRACTORY TO  GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF).

EHA Library, Maria Florencia Mininni, 4209696

CLINICAL SPECTRUM OF HOMOZYGOUS PATHOGENIC FANCD2 MUTATIONS: A CASE SERIES OF FOUR PEDIATRIC PATIENTS

EHA Library, Çağrı Coşkun, 4209700

SHORT- AND LONG-TERM OUTCOMES OF EQUINE ANTITHYMOCYTE GLOBULIN-BASED DOUBLE AND TRIPLE IMMUNOSUPPRESSIVE THERAPY IN APLASTIC ANEMIA: A SYSTEMATIC REVIEW

EHA Library, Austin G. Kulasekararaj, 4209705

A PIVOTAL PHASE 3 STUDY TO INVESTIGATE EFFICACY, SAFETY, AND TOLERABILITY OF MAVORIXAFOR IN PARTICIPANTS WITH PRIMARY CHRONIC NEUTROPENIA – TRIAL UPDATE

EHA Library, Deb Steiner, 4209706

ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA AS A PRECURSOR TO MARROW FAILURE AND CLONAL DISEASE: A SCOPING REVIEW OF PROGRESSION CASES

EHA Library, Shehab Fareed, 4209708

DISSEMINATED KAPOSI SARCOMA COMPLICATING UNTREATED FANCONI ANEMIA–ASSOCIATED VERY SEVERE APLASTIC ANEMIA

EHA Library, Rihab Ben Sghaier, 4209709

NFKB1 INSUFFICIENCY PRESENTING AS CONGENITAL CYTOPENIAS

EHA Library, Krishna Gundabolu, 4209710

THE FIRST REPORTED CASE OF REVESZ SYNDROME IN SAUDI ARABIA: CLINICAL AND MOLECULAR CHARACTERIZATION

EHA Library, Abrar Aljunaid, 4209711

A SYSTEMATIC REVIEW OF REAL-WORLD EVIDENCE ON THERAPIES FOR MODERATE APLASTIC ANEMIA

EHA Library, Britta Höchsmann, 4209712

ATLAS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ADAPTIVE SEAMLESS PHASE 2/3 STUDY TO ASSESS THE SAFETY AND EFFICACY OF MOMELOTINIB IN PATIENTS WITH VEXAS SYNDROME

EHA Library, David Beck, 4209713

SUCCESSFUL USE OF NSAIDS IN GHOSAL SYNDROME THERAPY: A CLINICAL CASE REPORT

EHA Library, Svetlana Lebedeva, 4209714

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A DISTRICT GENERAL HOSPITAL: A SIX MONTH CASE SERIES HIGHLIGHTING DIAGNOSTIC CHALLENGES AND THE VALUE OF EARLY MULTIDISCIPLINARY MANAGEMENT

EHA Library, Benjamin Lau, 4209715

FLOW CYTOMETRY IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RELEVANCE OF THE MONITORIZATION OF THE ERYTHROID CLONE SIZE IN PATIENTS WITH COMPLEMENT INHIBITORS THERAPY.

EHA Library, María Dolores Linares Latorre, 4209719

SARCOIDOSIS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A RARE CATASTROPHIC OVERLAP WITH MULTIORGAN FAILURE

EHA Library, Mai abouzeid, 4209720

DIAGNOSTIC CHALLENGES OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS MIMICKING AUTOIMMUNE CYTOPENIA IN A RESOURCE-LIMITED SETTING.

EHA Library, Brandi Afontin Gabriel, 4209722

THE MECHANISM OF STAT3 INHIBITORS INDUCING DNA DAMAGE IN MULTIPLE MYELOMA CELLS AND ENHANCING THE ANTI-TUMOR EFFECTS OF NK CELLS

EHA Library, Rong Fu, 4209723

THE EPIGENETIC ROLE OF CYCLIN D1 IN T(11;14) MULTIPLE MYELOMA

EHA Library, Katrina Fordwor-Hepburn, 4209724

MELFLUFEN TREATMENT MAY BE PARTICULARLY EFFECTIVE IN IMMUNOCOMPROMISED PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Philipp Sergeev, 4209727

URINE PCR/ACR DISCORDANCE DEFINES A RENAL PROTEIN PHENOTYPE AND INDEPENDENTLY ASSOCIATES WITH RENAL IMPAIRMENT IN MULTIPLE MYELOMA

EHA Library, Mamta Garg, 4209730

BONE MARROW STROMAL PROTEOMICS IDENTIFIES DETERMINANTS OF TREATMENT RESPONSE IN MULTIPLE MYELOMA.

EHA Library, Aishwarya Dash, 4209732

GUT LACTIC ACID BACTERIA PROMOTE MULTIPLE MYELOMA PROGRESSION BY UPREGULATING PRDX2 TO INHIBIT FERROPTOSIS AND REMODEL THE IMMUNE MICROENVIRONMENT

EHA Library, Liansheng Zhang, 4209734

TARGETING CD38 BEYOND DARATUMUMAB: A REAL-WORLD MULTICENTRE EXPERIENCE WITH ISATUXIMAB COMBINATIONS IN DARATUMUMAB-EXPOSED MULTIPLE MYELOMA.

EHA Library, Paula Gili Herreros, 4209735

EARLY DETECTION OF MULTIPLE MYELOMA AND MGUS PROGRESSION RISK USING ARTIFICIAL INTELLIGENCE AND ROUTINE LABORATORY DATA

EHA Library, Ciro Rinaldi, 4209739

PROTEASOME INHIBITION TRIGGERS RIBOSOME COLLISIONS AND TRANSLATIONAL REPROGRAMMING IN MULTIPLE MYELOMA CELLS

EHA Library, Monica Roman-Trufero, 4209740

MAF CONVERTS METABOLIC STATE INTO SUPERENHANCER ARCHITECTURE AND DEPENDENCY IN MYELOMA

EHA Library, Phyllis SY Chong, 4209742

EVALUATING MLPA AS A COST‑EFFECTIVE DIAGNOSTIC TOOL IN MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE COMPARISON WITH CYTOGENETICS AND FISH

EHA Library, Anna Szilágyi, 4209645

EFFICACY EVALUATION OF LUSPATERCEPT IN MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS WITH SF3B1 MUTATIONS WHO HAVE FAILED HYPOMETHYLATING AGENT THERAPY

EHA Library, Guangsheng He, 4209648

CLINICAL AND PATHOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND OTHER RELATED MYELOID DISORDERS

EHA Library, Angham Sahli, 4209651

EFFICACY AND SAFETY OF SELINEXOR IN COMBINATION WITH AZACITIDINE FOR THE TREATMENT OF HIGHER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Jun Qian, 4209652

TREATMENT OF HIGHER RISK MYELODYSPLASTIC SYNDROME HR-MDS WITH HIGH-DOSE CHEMOTHERAPY FOLLOWED BY LENALIDOMIDE AND AZACITIDINE: A THREE YEARS SURVIVAL UPDATE

EHA Library, Maher Salamoon, 4209653

HOTSPOT GENE MUTATIONS AND TREATMENT RESPONSE IN MYELODYSPLASTIC SYNDROMES (MDS): PREDICTIVE BIOMARKERS AND TARGETED STRATEGIES

EHA Library, Rui Zhang, 4209659

PATTERNS OF AZACITIDINE RESISTANCE IN HIGH-RISK MDS: REAL-WORLD DATA FROM A SINGLE CENTER.

EHA Library, Pablo Prieto-Martinez, 4209660

EFFECTIVE TREATMENT 3 CASES OF MDS BI-TP53/MDS-F WITH LOW-DOSE DECITABINE COMBINED WITH LOW-DOSE SELINEXOR

EHA Library, Gaixiang Xu, 4209661

TWO TYPES OF STROMAL PRECURSORS FROM THE BONE MARROW OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA REVEAL SIMILAR CHANGES IN GENE EXPRESSION, INDICATING ALTERATIONS IN MESENCHYMAL STEM CELLS

EHA Library, Irina Shipounova, 4209664

DECIPHERING BONE DISEASE IN GAUCHER DISEASE: INTEGRATED ENDOCRINE AND MOLECULAR SIGNATURES

EHA Library, Sonia Roca Esteve, 4209665

TERT INTRON 4 RETENTION AS A NOVEL MECHANISM OF TELOMERE BIOLOGY DISORDERS

EHA Library, Fernanda Gutierrez-Rodrigues, 4209667

THE INVOLVEMENT OF T-REGULATORY CELLS IN THE PATHOGENESIS OF CHRONIC IDIOPATHIC NEUTROPENIA

EHA Library, Nikoleta Bizymi, 4209668

MOLECULAR CHARACTERIZATION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: SPECTRUM OF PIGA MUTATIONS AND ASSOCIATED SOMATIC ALTERATIONS

EHA Library, Patrycja Mensah-Glanowska, 4209669

PHENOTYPIC PROFILE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES (≥ 5%) IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA : A MONOCENTRIC STUDY

EHA Library, Salima Oukid, 4209672

RESEARCH ON THE MECHANISM OF DENDRITIC CELLS INVOLVEMENT IN THE IMMUNE ESCAPE OF PNH CLONES IN PATIENTS WITH CLASSICAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Rong Fu, 4209673

OSTEOGENIC POTENTIAL OF BONE MARROW DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS FROM APLASTIC ANEMIA PATIENTS WITH ASEPTIC NECROSIS OF THE FEMORAL HEAD

EHA Library, Alena Dorofeeva, 4209674

GENDER-DEPENDENT ALTERATIONS IN THE ABILITY OF MULTIPOTENT MESENCHYMAL STROMAL CELLS TO RESPOND TO OSTEOGENIC INDUCTION IN APLASTIC ANEMIA

EHA Library, Alena Dorofeeva, 4209675

IDENTIFICATION OF A NOVEL TERC VARIANT IN THE H/ACA BOX WITH REVERTANT SOMATIC MOSAICISM IN DYSKERATOSIS CONGENITA

EHA Library, René Mulder, 4209676

EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS COMBINED WITH INTENSIVE IMMUNOSUPPRESSIVE THERAPY PLUS UMBILICAL CORD BLOOD TRANSFUSION FOR SEVERE APLASTIC ANEMIA

EHA Library, Fang Zhou, 4209681

REAL-WORLD PHYSICIANS AND PATIENTS PERSPECTIVES ON ADHERENCE, SATISFACTION WITH PEGCETACOPLAN, AND HEALTH RELATED QUALITY OF LIFE ACROSS EUROPE, THE UNITED STATES AND CANADA: A CROSS-SECTIONAL STUDY

EHA Library, Jens Panse, 4209682

SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MY008211A, AN ORAL COMPLEMENT FACTOR B INHIBITOR, IN SINGLE- AND MULTIPLE-ASCENDING-DOSE STUDIES IN HEALTHY PARTICIPANTS

EHA Library, Xin Li, 4209683

IMMUNOSUPPRESSIVE TREATMENT IN ELDERLY PATIENTS (>60 YEARS) WITH ACQUIRED APLASTIC ANEMIA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS

EHA Library, Alessandra Tucci, 4209684

CARDIAC STRUCTURAL ABNORMALITIES, IRON OVERLOAD, AND PROGNOSTIC IMPLICATIONS IN FANCONI ANEMIA: A SINGLE-CENTER COHORT STUDY

EHA Library, Beril Kiracı Şen, 4209687

SINGLE CENTRE REVIEW OF APLASTIC ANAEMIA: FANCONI, TELOMERE AND INHERITED BONE MARROW FAILURE TESTING

EHA Library, Morag Griffin, 4209688

INCIDENCE RATES OF SERIOUS INFECTIONS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A REAL-WORLD COMPARISON USING DATA FROM TRINETX ACROSS THE US, EUROPE, AND OTHER REGIONS

EHA Library, Håkan Malmström, 4209689

FIRST REPORT OF REAL-WORLD EXPERIENCE WITH IPTACOPAN AS INITIAL ORAL MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN MEXICO

EHA Library, Andrea Mirelly Lopez Flores, 4209694

SEVERE APLASTIC ANEMIA IN A MOROCCAN CENTER: REAL-WORLD TREATMENT OUTCOMES

EHA Library, Zineb Guessous, 4209697

EFFICACY OF ADDING PEGFILGRASTIM TO IMMUNOSUPPRESSIVE THERAPY IN APLASTIC ANEMIA PATIENTS- AN OPEN LABELED RANDOMIZED PILOT STUDY FROM SOUTH INDIA.

EHA Library, Deepak Amalnath, 4209698

A NOVEL DE NOVO RPS19 MUTATION CONFIRMS ATYPICAL DIAMOND-BLACKFAN ANEMIA IN AN ADULT PATIENT: A CASE REPORT

EHA Library, Lijuan Zhang, 4209699

FIRST-IN-HUMAN, FIRST-IN-PATIENT STUDY OF ALN-CFB, AN INVESTIGATIONAL SIRNA TARGETING HEPATIC COMPLEMENT FACTOR B: TREATMENT OF PERSISTENT ANEMIA IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Nikhil Singh, 4209701

EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A MULTI-CENTER RETROSPECTIVE STUDY IN SOUTHERN CHINA

EHA Library, Gaixiang Xu, 4209702

THE IMPROVEMENT OF RENAL FUNCTION BY COMPLEMENT INHIBITORS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Guangsheng He, 4209703

ACQUIRED APLASTIC ANAEMIA: CLINICO-HAEMATOLOGICAL FEATURES, MANAGEMENT AND LONG TERM OUTCOMES IN PATIENT INELIGIBLE FOR ALLOGENEIC TRANSPLANT

EHA Library, Nabila Rekab, 4209704

PERSISTENT ANEMIA FOLLOWING ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Guangsheng He, 4209707

AUTOIMMUNE CYTOPENIAS AS THE INITIAL PRESENTATION OF COMMON VARIABLE IMMUNODEFICIENCY

EHA Library, María del Valle Recasens Flores, 4209716

EFFICACY AND SAFETY  OF ECULIZUMAB  IN 47 PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHINA:A MULTI-CENTER REAL-WORLD STUDY

EHA Library, Gaixiang Xu, 4209717

REAL-WORLD EXPERIENCE WITH IPTACOPAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: EFFICACY IN TREATMENT-NAÏVE AND SWITCH PATIENTS

EHA Library, Ting Wu, 4209718

CLINICAL EFFICACY OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN PULSE THERAPY IN CHILDREN WITH STAGE IV HIGH-RISK NEUROBLASTOMA COMPLICATED BY SECONDARY BONE MARROW FAILURE

EHA Library, Jianming Fang, 4209721

TARGETING DORMANT MULTIPLE MYELOMA CELLS BY INDUCING OXIDATIVE STRESS

EHA Library, Chloe Harris, 4209725

GENETIC ABERRATIONS IN MULTIPLE MYELOMA REVEALED BY OPTICAL GENOME MAPPING

EHA Library, Balázs Kardos, 4209726

DEVELOPMENTAL TOXICITY AND NEUROBEHAVIORAL EFFECTS OF POMALIDOMIDE ON ZEBRAFISH (DANIO RERIO) EMBRYOS: IMPLICATIONS FOR THE SAFETY PROFILE OF IMMUNOMODULATORY DRUGS

EHA Library, Dimitrios Leonardos, 4209728

PROGNOSTIC SIGNIFICANCE OF DYNAMIC CHANGES IN BONE MARROW B-CELLS, PLASMA CELLS AND T-CELLS IN WALDENSTRÖM MACROGLOBULINEMIA PATIENTS.

EHA Library, Sarah Dobin, 4209729

THE NONO INTERACTOME IN MULTIPLE MYELOMA: MAPPING PROTEIN PARTNERS AND REGULATORY PATHWAYS

EHA Library, Elisa Taiana, 4209731

DNA DAMAGE REPAIR (DDR) RELATED PROGNOSTIC RISK MODEL IN MULTIPLE MYELOMA BASED ON SINGLE-CELL AND BULK SEQUENCING

EHA Library, Hongxiu Liu, 4209733

REAL-WORLD EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN–BASED CONTAINING REGIMEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A EMN LAZIO WORKING GROUP EXPERIENCE.

EHA Library, Marco Zomparelli, 4209736

TUMOR-SPECIFIC CELL-FREE DNA FOR MONITORING DISEASE ACTIVITY IN MULTIPLE MYELOMA WITH PARASKELETAL AND EXTRAMEDULLARY PLASMACYTOMAS

EHA Library, Martin Stork, 4209737

HETEROGENEITY OF THE PLASMA CELL CLONE AT THE ONSET OF PLASMA CELL NEOPLASMS: A COMPARATIVE ANALYSIS

EHA Library, Veronika Pinchuk, 4209738

ELTROMBOPAG TARGETS PNPO TO SUPPRESS WNT/Β-CATENIN SIGNALING AND SYNERGIZE WITH CYCLOPHOSPHAMIDE–PREDNISONE IN MULTIPLE MYELOMA

EHA Library, Fan Zhou, 4209741

EPIGENETIC MODIFIER GSK-J4 ENHANCES SENSITIVITY TO VENETOCLAX IN MULTIPLE MYELOMA

EHA Library, Stephanie Gilmore, 4209743